Treatment of fibrous dysplasia: focus on denosumab.
Bogdan HuzumSabina Antonela AntoniuRaluca DragomirPublished in: Expert opinion on biological therapy (2021)
Denosumab is a potential therapeutic agent against FD. A combined synergic approach involving theranostics might increase its therapeutic potential.